News
Deepali brings over 30 years of extensive experience in brand building, marketing, and corporate reputation management across ...
Naair will report to CEO Shreehas Tambe and joins the Executive Leadership Team; Seema Ahuja to transition to a new role in ...
Bengaluru: Biocon Biologics Limited, a fully integrated global biosimilars company and a subsidiary of Biocon Limited, has ...
Naair will lead Biocon Biologics' global brand and corporate communications strategy as part of its executive team, reporting ...
Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced it ...
Biocon Biologics has appointed Deepali Naair as the global head of brand and corporate communications. Naair, with three ...
2d
Capital Market on MSNBiocon edges higher after biologics arm launches autoimmune treatment drug Nepexto in AustraliaNepexto will be promoted by Generic Health, BBL's local partner and a leading provider of high-quality generic prescription, ...
The shares of biopharmaceutical firm Biocon fell as much as 2.04 per cent in Tuesday's trading session, figuring among top ...
Etanercept is a TNF (tumor necrosis factor) inhibitor used to treat several autoimmune conditions, including rheumatoid ...
Biocon's subsidiary, Biocon Biologics, has introduced Nepexto, a biosimilar to Enbrel (Etanercept), in Australia for treating ...
Shares of Biocon experienced a decline of 2.01% to Rs 386.70 in Tuesday's session, with the stock figuring among the top ...
Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results